Cells, genetics and birth defects'
In opening the meeting, Professor P E Polani pointed to the dichotomous nature of the work taking place at Guy's Paediatric Research Unit. On the one hand, methods are being devised and utilized for prenatal diagnosis and thus selective abortion of individuals affected by serious and untreatable genetic disorders, so helping parents who otherwise would not be able to face the risk of further affected children; while on the other hand, ways are being sought for primary prevention and for the treatment of defects. He also emphasized the importance of cooperation between disciplines in the work of a research and service unit.
Professor Polani introduced six members of his staff chosen to present representative topics of research or service work which he considered to be of particular interest to the Section of Paediatrics. Dr Mary J Seller discussed a mouse model for neural tube defects in man. Aspects of the lesions of the neural tube in the mutant mouse, curly-tail, closely resemble those seen in humans. Both ends of the neural tube may be affected, so both spina bifida and exencephalythe rodent form of anencephalyoccur. In both mice and men, prenatally, open lesions are associated with polyhydramnios, elevated levels of amniotic fluid alphafetoprotein (AFP), and the presence of rapidly adhering cells with characteristic morpology in the liquor. There is a female excess amongst the affected individuals which is most marked in the anencephalics/exencephalics. Hydrocephaly is sometimes also associated.
In man the aetiology is thought to be multifactorial, involving both genes and certain, as yet unknown, environmental factors. In the curlytailed mouse such a gene/environment interaction has been demonstrated. Further, it has been found that it is possible to reduce the incidence of neural tube defects far below that spontaneously occurring by administering certain doses of vitamin A to the pregnant mouse on the day after the neural tube should have closed. This finding may have far-reaching effects in prevention.
Dr M Adinolfi described possible immunological mechanisms of prenatal damage to the central nervous system. It has long been recognized that the development of the brain and the unfolding of behaviour are sensitive to modification by environmental changes during certain periods of fetal and perinatal growth. The hypothesis that maternal antibodies against brain antigens may 'Report of meeting of Section of Paediatrics, 23 March 1979. Accepted 4 May 1979 affect the development of the brain is being tested. This hypothesis is based on two assumptions. The first is that antibrain antibodies should be present in sera from normal individuals and pregnant women; the second is that such maternal antibodies should cross the placenta and reach the fetal circulation and the brain tissues.
There is now evidence that antibodies against brain antigens are indeed present in about 10% of normal individuals. It has also been shown that the permeability of the blood-brain barrier to plasma proteins is incomplete during fetal and perinatal life in man. High levels of albumin, AFP and IgG have been detected in the CSF of human fetuses over 12 weeks of age. Experimental work has also shown that the maturation of the blood-CSF barrier is incomplete during fetal and perinatal life in rats.
Work is now in progress to study the effect that antibodies against brain antigens may have on the development of the rat brain after being injected into pregnant or newborn rats. Preliminary evidence suggests that antimyelin antibodies reduce the synthesis of myelin and induce paralysis if injected into pregnant rats at the end of gestation or in 1day-old rats. It is felt that antimyelin antbodies and antibrain antibodies with various specificities may be useful in the investigation of brain maturation and the development of behaviour. They may also help to elucidate the origin of certain forms of congenital mental retardation and other neurological handicaps in man.
Dr Eva Alberman described an epidemiological and cytogenic survey which had provided information on the recurrence risk following a trisomic abortus. In a previous report she had shown with the use of pooled data from this and another study that there was a high risk of recurrence of trisomic abortions, sometimes involving different chromosomes. However, nothing was known of the risk of trisomic livebirths after such abortions. In order to answer this question, patients who had been discovered to have produced a trisomic fetus were traced and interviewed at a minimum ofthree years and a maximum of six years after the event. Of 62 mothers, 47 had become pregnant again after the index abortion, and had 65 pregnancies. Seven of these had been terminated for social reasons, 12 had aborted spontaneously. One baby was delivered at 24 weeks' gestation and died with no evidence of abnormality. Another baby also died in the neonatal period but was diagnosed as having trisomy 18 (Edward's syndrome). There was no evidence of any chromosome abnormality in the 0 9© 1979 The Royal Society of Medicine 0 1 41-0768/79/08062-4-03/$O1.00/0 remaining pregnancies, 7 of which were shown to have normal chromosome complements as they had had amniocentesis.
Another group of women who had had a previous trisomic fetus and who had amniocentesis in their next pregnancy were also studied. All 23 of these had normal outcomes.
Adding together the data from both groups, one out of 69 livebirths was found to be chromosomally abnormal. Notwithstanding the wide confidence limits of small numbers, this suggests that the risk of a chromosome anomaly compatible with survival in pregnancies following a trisomic abortus is likely to be of the same order as the 1% following a trisomic livebirth.
Dr F Giannelli explained how the apparent stability of DNA is in fact an illusion. The hereditary material is not inherently stable, but normal individuals have efficient inbuilt surveying systems for spotting DNA damage, and equally efficient repair mechanisms. Various physical and chemical environmental agents cause an almost infinite variety of lesions in the genetic material, but cells are endowed with many different DNA repair pathways. Defects in such pathways may have serious consequences, as illustrated by diseases such as xeroderma pigmentosum, ataxia telangiectasis, Fanconi anaemia, Bloom and Cockayne syndromes, which are characterized by developmental abnormalities, often degenerative changes in the central nervous system, heightened sensitivity to environmental mutagens and suscepibility to cancer.
These disorders are inherited in an autosomal recessive manner and are rare and they may seem to contribute little to human morbidity. However, the DNA repair defects discovered so far affect only few of the DNA repair functions known to exist in man and discovery of new defects is likely. In addition, there are data to show that at least the heterozygous carriers of the mutations responsible for xeroderma pigmentosum, ataxia telangiectasis and Fanconi anaemia are unduly prone to malignancy. These heterozygotes may represent as much as 3% of the general population and may contribute significantly to that section of the population which develops cancer because it is genetically predisposed to it.
Following experimental work on mice done by others in the Paediatric Research Unit to correct genetic cellular defects by the implantation of normal cells, Dr P F Benson and Miss L Button (together with Dr M F Dean and Dr H Muir of the Kennedy Institute of Rheumatology) have investigated this method of treatment of certain inborn errors of metabolism in man, by fibroblast transplantation. Two hundred million HLA identical cells derived from a parent or sibling, cultured first in vitro, have been transplanted subcutaneously into 3 patients with Sanfilippo type A disease, in an attempt to provide a long-lasting source of the deficient enzyme -heparan N-sulphatase. Following transplantation, evidence of elevated enzyme activity persisted for several years and was accompanied by increased excretion and catabolism of stored glycosaminoglycans. Although immunosuppressive therapy was given to minimize the risk of graft rejection, it was not itself responsible for the increases observed, since these persisted after therapy was stopped. This approach may be successful in genetic enzyme deficiencies where the relevant enzymes are produced by fibroblasts, exported and taken up into the lyosomes of the patient's cells.
Dr Caroline Berry discussed some of the dilemmas encountered in genetic counselling. Three cases illustrated the way in which advances, particularly with prenatal diagnosis, may give rise to problems for both patients and their advisers.
The mother of a 2-year-old only child suffering from xeroderma pigmentosum but living a normal life came for counselling to learn of her risks in order to decide whether to embark upon another pregnancy. The risk of recurrence is 1 in 4 and prenatal diagnosis (PND) allows an affected fetus to be detected by 20 weeks' gestation. Because the parents in this case had not experienced the difficulties of bringing up a child who has to be protected constantly from the sun and because they had not seen the scarring, disfigurement and skin cancers that the disease produces, they found it difficult to grasp the seriousness of the condition. Before a mother can accept the idea of a late termination of pregnancy when the fetus is affected, she must be fully convinced that the condition warrants such action, as well as finding such action compatible with her moral and religious principles. This may be difficult when the affected child appears to be progressing well.
Somewhat similar are the problems for those who themselves suffer from a condition for which PND is available. An 18-year-old girl who was quite severely handicapped by a myelomeningocoele became pregnant and, in view of her 4% risk of having a similarly affected child, thought that PND was a wise course of action. An abnormal fetus was detected and the pregnancy terminated. Other people in her position find the suggestion of PND offensive since they believe that it can be taken to reflect the attitude that a handicapped life is worthless. Since there are quite a number of such young people in the population it is important that they should receive sympathetic counselling at an appropriate time, though there are likely to be differences of opinion as to the timing and source of such advice.
The final case was that of a sensitive young man suffering from a dominant form of syndactyly of hands and feet. Despite an excellent repair he was acutely concerned about the possibility of having a similarly or more gravely affected child. Fetoscopy could allow the detection of an affected fetus early enough for termination of the pregnancy, but the possible limitations and risks of this procedure also had to be considered. The fact that PND is now becoming available for conditions that may not result in major handicap raises serious ethical issues for counselled and counsellors alike.
MARY J SELLER

Senior Lecturer in Experimental Biology
Paediatric Research Unit Guy's Hospital Medical School Who says I'm unfit for work?'
It was hardly surprising that Dr J J McMullan, a general practitioner, Mr B Cogger, a personnel officer and Dr K H Nickol, an occupational health physician, should give three different answers to this question when it was posed at a meeting of the Section of General Practice, to which members of the Section of Occupational Medicine particularly were invited, and it certainly stimulated a lively discussion.
The initial move is made by the patient when he decides to stay away from work to attend the surgery, or even to remain in bed, and Dr J J McMullan agreed with the views of Came (1969) that in most cases not only does the doctor do no more than countersign the patient's own declaration of his unfitness to work, but that in acute non-serious cases his advice is largely irrelevant and the requirement to produce a certificate for insurance or place of work may even prolong the absence. It is also necessary to reaffirm periodically that a general practitioner's job is primarily to see that no one gets to work who is ill and not that no one is absent who is well (Hodgkin 1970) .
Mr B Cogger pursued an interesting mechanistic analogy that it was the employer who decided what resources, human and material, he needed to do a particular job: not only quantitatively, but also qualitatively, which means that he must determine the level of fitness required on the one hand and the degrees of disability acceptable on the other. Moreover, just as he buys, maintains, repairs and finally sells or scraps his machinery, so he recruits, trains, allows for medical care and finally retires on age or medical grounds his work force. His basic objective is to ensure that his assets, human and material, are working as efficiently as possible for as long as possible.
The satisfactory resettlement of a worker with a medical restriction on his capabilities may involve his colleagues at work, his supervisor and his union representative, as well as the personnel officer and medical officer. It is essential that the medical officer should have full information from the general practitioner and/or the hospital as soon as possible if he is to give sound advice, and perhaps fortunate for him that, having given the advice, the solution ofthe problem rests with the personnel officer, as on occasion it may appear to be almost insoluble. The search for a solution often has its lighter moments, however, and a satisfactory conclusion can be a good morale booster to all concerned.
Dr K H Nickol dealt with many aspects of occupational medicine in relation to fitness for work. He pointed out that treatment may prolong unfitness by considering only the patient and failing to rehabilitate him for his specific job. An occupational physician may help the unfit to become fit by his knowledge of the job or by negotiating easier work. Some employees cannot be allowed to work in certain jobs because of, for example, unstable epilepsy or diabetes.
In all but the most simple and straightforward cases rehabilitation must be a joint effort. In a small unit with a small catchment area, an effective liaison between the occupational health nursing officer, personnel officer and general practitioner, who may well be doubling as the part-time occupational physician, should be easy to establish. The problem is to establish an equally effective relationship in a large unit-with a widely scattered catchment area involving at least dozens ofgeneral practitioners.
If time is short and priorities have to be set, it is perhaps understandable that a general practitioner should pay more attention to establishing good relations with the hospital service than with
